Clinical-pharmacist intervention reduces clinically relevant drug–drug interactions in patients with heart failure: A randomized, double-blind, controlled trial

Intervenções Farmacêuticas Em Uma Unidade De Terapia Intensiva De Um Hospital Universitário

“…Diante do exposto, salienta-se a importância da atuação do farmacêutico na equipe multiprofissional direcionado a cuidados intensivos, com o intuito de promover uma melhor assistência e colaborar para o incremento da segurança do paciente, além de propiciar resultados que influenciem diretamente nos indicadores em saúde 3,5,[12][13][14][15] . Entretanto, apesar da existência de uma vasta literatura internacional a respeito da atuação do farmacêutico clínico intensivista, no Brasil, estudos como este, são ainda escassos [3][4][5]11,14 .…”

The role of the pharmacist in the care of patients with cardiovascular diseases

“…One recent study showed that the preparation of a special notification system for doctors on clinically relevant drug interactions leads to an improved safety profile of the patients. Despite the reduction of adverse drug reactions at the end of hospitalisation, Roblek et al [45] did not observe the impact of this phenomenon on the endpoint of the research, i.e. re-hospitalisation or death in the six-month follow-up.…”

Impact of providing psychiatry specialty pharmacist intervention on reducing drug-related problems among children with autism spectrum disorder related to disruptive behavioural symptoms: A prospective randomized open-label study

“…Pharmacist intervention has been addressed and proved to reduce DRPs in a variety of chronic disorders. Adverse drug events, drug interactions and medication adherence were also improved by pharmacist intervention when compared with usual care in patients with heart failure, cardiovascular diseases, hypertension and diabetes mellitus . In child psychiatric setting, DRPs such as medication overuse, adverse drug reactions (ADRs) and drug interaction have been identified in patients with mental retard and developmental disabilities .…”